Sri Lanka Ministry of Healthcare and Nutrition Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2007
NCT00463684
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Epidemiological Unit, Sri Lanka Ministry of Healthcare and Nutrition

Active Ingredients

Drugs in Phase 3 Trials (1)

live attenuated chimeric japanese encephalitis vaccine (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Encephalitis (Phase 3)

Encephalitis, Japanese (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1